Accent Therapeutics is developing small molecule, precision cancer therapies in the emerging field of epitranscriptomics. This area of biology encompasses post-transcriptional chemical modifications of RNA that provide cells with a unique mechanism for regulating proteins critical for cellular growth and differentiation. By targeting cancer-linked RNA-modifying proteins (RMPs) with precision drugs, Accent is translating extraordinary, novel science into life-changing therapies for patients.
| Headquarters | Lexington, MA |
| Website | www.accenttx.com |
| Pipeline | Preclinical |
| @accent_tx |